Mark Logsdon, MD
Radiation Oncology · Sacramento, CANPI 1669479853
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Brainlab, Inc. at 46.8% of the total. 2025 is the largest year on record at $1,350, 8.7 times the $156 reported in 2019.
Across 11 payments — averaging $194.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brainlab, Inc.$1K
- Bioprotect Medical, Inc.$483
- Reflexion Medical, Inc.$444
- Boston Scientific$181
- Palette Life Sciences, Inc.$29
What the payments were for
- Speaking & faculty fees$1,00047%
- Travel & lodging$26913%
- Food & beverage$86741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brainlab, Inc. | 1 | $1,000 |
| Bioprotect Medical, Inc. | 5 | $483 |
| Reflexion Medical, Inc. | 2 | $444 |
| Boston Scientific | 2 | $181 |
| Palette Life Sciences, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,136 in reported general payments places this provider in the 75th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 41 | $113,524 |
| Tamsulosin Hcl | 278 | $3,527 |
| Bicalutamide | 14 | $204 |
| Omeprazole | 11 | $177 |
| Ciprofloxacin Hcl | 25 | $50 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Sacramento
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
- Hyun KimDuarte$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.